Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Dexrazoxane for anthracycline extravasation.

Dexrazoxane for anthracycline extravasation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Dexrazoxane for anthracycline extravasation. Abstract Text:

    seppo w langerSeppo W Langer,seppo w langerSeppo W Langer,seppo w langerSeppo W Langer,

    Accidental extravasation of anthracycline-containing anticancer chemotherapy is a feared complication that may lead to progressive tissue damage. The condition may require extensive surgical intervention and often has severe long-term effects. Until a short while ago, there has been no effective treatment against the devastating effect of extravasated anthracycline. However, dexrazoxane has proven highly effective in preventing necrosis in both preclinical and clinical studies and is now approved in Europe (Savenetrade mark), and has orphan drug status in the USA (Totecttrade mark) for this indication. Hence, it is the first and only proven effective antidote against anthracycline extravasation injuries.

    Dexrazoxane for anthracycline extravasation. Publishing Authors By Initials

    sw langerSW Langer,sw langerSW Langer,sw langerSW Langer,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Dexrazoxane for anthracycline extravasation. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Expert review of anticancer therapy

    VOLUME: 7

    Page Numbers: 1081-8

    Journal Abbreviation: Expert Rev Anticancer Ther

    ISSN: 1744-8328

    DAY: 21

    MONTH: Aug

    YEAR: 2007

    Dexrazoxane for anthracycline extravasation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101123358

    Dexrazoxane for anthracycline extravasation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Dexrazoxane for anthracycline extravasation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Dexrazoxane for anthracycline extravasation.

    AFFILIATION: Chief Medical Oncologist, Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Section 5073, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. seppo.langer@rh.regionh.dk.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Anticancer Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Dexrazoxane for anthracycline extravasation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News